Earlier signal, clearer action
Built for high-need care settings, where repeatable biomarker insight supports better follow-up and sharper decision windows.
A new cadence for molecular disease monitoring.
Centralized tests happen too rarely to see disease change as it unfolds. LBx Bio is developing a compact platform that monitors molecular signals in the intervals between — surfacing meaningful change earlier and routing it into confirmatory testing through existing clinical workflows.
Product rendering for illustrative purposes. Investigational device; not available for sale.
Beginning in oncology.
Oncology is where the gaps cost the most. Disease trajectory, treatment response, recurrence risk, and follow-up decisions all turn on visibility that centralized testing leaves incomplete.
Longitudinal disease visibility
Disease seen over time, not as isolated testing moments.
Clinical monitoring infrastructure
Designed to connect biomarker signal, patient trajectory, and clinical context into a single monitoring layer.
Our partners
